- Global Pharma News & Resources

BioWave Corporation Announces Launch of BioWaveGO Introducing Effective, Non-opioid, Over-the-counter Pain Relief Technology to Millions of People

BioWave Corporation Announces Launch of BioWaveGO Introducing Effective, Non-opioid, Over-the-counter Pain Relief Technology to Millions of People BioWave's Professional Athlete Proven and U.S. Military Trusted Smarter Pain Blocking Technology Helps People Lead a Fuller & Active Pain-Free Life

PR Newswire

NORWALK, Conn., Jan. 8, 2019

NORWALK, Conn., Jan. 8, 2019 /PRNewswire/ -- BioWave Corp., a Health Technology company that delivers Smarter Pain Blocking Technology™ today announced the launch of BioWaveGO a new FDA cleared, over the counter version of its popular, non-opioid, patented, pain relief technology.

BioWave products are Professional Athlete proven and U.S. Military trusted and is currently used by most NFL, NBA, NHL, and MLB teams, 160+ college programs, over 80 VA hospitals, as well as by pain doctors nationally.

The development of the new BioWaveGO OTC product is the natural evolution of a patented neurostimulator pain relief technology that BioWave has perfected over more than ten years. BioWaveGO is available in a wearable, non-prescription strength to help anyone in acute or chronic pain lead a fuller and active pain-free life.  BioWave technology is different than old-fashioned TENS and has been proven effective, significantly reducing pain from just one 30-minute treatment and comes with a 30-day money back guarantee.

"It has been my dream to bring the life-changing BioWave technology to the public in a non-prescription version that can help anyone easily and inexpensively significantly reduce the often-daily torment of acute or chronic pain," said Brad Siff, President, and Founder of BioWave Corporation. "BioWave is a life-changing non-opioid, non-addictive, effective smarter pain blocking technology."

BioWave's FDA-cleared, high-frequency neurostimulation technology, described in more detail on its website, delivers soothing therapeutic signals through the skin into deep tissue, blocking pain signals at the source.

"We couldn't be more excited to launch BioWaveGO as we further scale our business and bring real, non-opioid relief to the millions of Americans that live with daily pain," commented Rob Wolter, BioWave CEO. "Feeling is believing, whether for veterans, active military, professional athletes, injured workers, or people from all walks of life that just want to be able to get around in their daily life, be active, and live pain-free."

BioWave is available under Federal Supply Schedule contract number V797D-70205.

BioWaveGo is available for purchase on the BioWave website.

About BioWave Corp.

BioWave is a health technology company that manufactures and sells a variety of FDA cleared medical devices, all based on its patented, high-frequency neurostimulation technology for natural, non-opioid pain relief. Products include BioWavePRO and BioWavePENS, for use in a physician's office, BioWaveHOME, a home prescription portable version, and BioWaveGO an over the counter wearable version. BioWave devices are in use by physicians nationwide, including at over 80 VA Hospitals as well as by over 120 professional sports teams across the NFL, NBA, NHL, and MLB, as well as by more than 160 NCAA programs and have been officially recommended by Vietnam Veterans of America (VVA). BioWave is proud to work with the Veteran's Administration who is leading the way with new non-opioid pain therapies to help Veterans treat all different types of chronic pain conditions.

Connect with the company Facebook or at


Marc Karasu
Chief Marketing Officer

View original content:


Editor Details

  • Company:
    • PR Newswire
  • Website:
Last Updated: 08-Jan-2019